Chai
Santa Clara-based biotech firm specializing in design, production, and marketing of qPCR solutions.
Founded
2013Santa Clara-based biotech firm specializing in design, production, and marketing of qPCR solutions.
Founded in Santa Clara, California, Chai is a biotechnology company dedicated to democratizing access to advanced molecular diagnostics. The company's core mission is to empower individuals and organizations by providing high-quality, affordable qPCR solutions. Chai designs, manufactures, and markets a range of products including the Open qPCR thermocycler, PCR reagents, master mixes, DNA/RNA extraction buffers, and various lab supplies. Their market focus spans scientists, educators, and industries such as brewing, ensuring broad applicability of their biotechnological innovations.
Chai has garnered attention for its innovative Open qPCR thermocycler, which is praised for its speed and accuracy. The company's leadership includes experts in biotechnology and engineering, contributing to its robust product development. Notable investors have supported Chai's mission to make advanced diagnostics more accessible. Key achievements include the successful deployment of their qPCR solutions in diverse settings and significant contributions to coronavirus testing efforts. Overall, Chai has made a substantial impact by simplifying complex biotechnological processes and expanding the reach of molecular diagnostics.
Companies similar to Chai include Igenesis, ChromaCode, Practichem and Combinati.
Chai was founded in 2013.
Chai's headquarters is located in Santa Clara, CA, US.
Chai's most recent funding round was for $5M (USD) in April 2017.
As of Apr 14, 2017, Chai has disclosed funding of $6.4M (USD). Undisclosed round amounts are excluded.
Chai has 50 employees as of Feb 4, 2024.
Combinati
